BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week
Oct 26, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. Epidermolysis Bullosa Global Awareness Week is Oct. 25-31, 2022. “In severe cases of epidermolysis bullosa, or EB, the very fragile skin tears easily and forms painful blisters and open wounds that do not heal quickly,” said Alexandra Mancini, SVP of Clinical and Regulatory Affairs for InMed. “EB is a very important but rare disease that does not get the attention it deserves. EB Awareness Week is an opportunity for the community to come together to raise awareness about epidermolysis bullosa to foster the necessary research and resources to work towards better treatments and, eventually, a cure to improve the lives of those with EB. InMed has undertaken a phase 2 study in patients with EB in the hope that its cannabinol cream will provide important symptom benefit.”
To view the full press release, visit https://ibn.fm/ZilLc
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, visit www.InMedPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Taylor Swift breaks two Spotify records with new music
Taylor Swift has made history with Spotify, including by becoming the most-streamed female artist in a day for 2026, through her new single and extended album.
Kris Jenner takes KUWTK home off the market
Kris Jenner has taken the Hidden Hills mansion where Keeping Up with the Kardashians was filmed, off the market.
Beck's tribute to Dolly Parton
Beck has paid tribute to late country music icon Dolly Parton, who he first met at a wedding when he was just a child.
Taylor Swift breaks two Spotify records
Taylor Swift has broken two Spotify records for 2026 with the release of The Life of a Showgirl: The Encore.
Robert Pattinson’s new movie blasted as 'exploitative and predatory'
Chris Hansen has blasted Robert Pattinson’s new movie about him as “exploitative and predatory” and said the team behind the film never reached out to him.
Sabrina Carpenter to play Ginger Rogers in Fred Astaire biopic
Sabrina Carpenter will join Tom Holland and Margaret Qualley in the upcoming Fred Astaire biopic.
Reba McEntire missed a call from Dolly Parton before her death
Reba McEntire missed a call from Dolly Parton before she died and never found out what the country music icon wanted.
Presley Gerber cremated and funeral plans underway
Presley Gerber - the 27-year-old model son of supermodel Cindy Crawford, 60, and businessman Rande Gerber, 64 and brother of model-and-actress Kaia Gerber, 25 - has been cremated, less than a week after his death.
'So lucky': Kylie lights up rain-soaked AFL grand final
Homegrown hero Kylie Minogue has dazzled the AFL grand final with pyrotechnics, wardrobe changes and a selection of her biggest hits.
Tom Cruise vows to keep pushing cinematic boundaries
Top Gun star Tom Cruise is determined to keep pushing himself as an actor because he wanted "adventure" from an early age.
Footy codes unite on Aussie rules' big day
A decades-old club tradition has again hosted a who's who of politics and Aussie Rules ahead of AFL's biggest day, where an unlikely star stole the limelight.
Sarah Ferguson denies claims she wants to ‘set the record straight’ in tell-all memoir
It was reported that Sarah Ferguson, the former Duchess of York, was "days away" from signing a seven-figure deal to work on a ‘tell-all book’.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.